Pemphigus is a group of rare skin disorders that cause painful blisters to develop on the skin as well as inside the mouth, nose, throat, anus and genitals.
Treatment is aimed at reducing pain and symptoms and to prevent complications like infection. It involves one or more drugs and other methods. It may include Corticosteroids and Immune-Suppressing Drugs, Antibiotics, Antivirals, Antifungals, IV Feeding, Plasmapheresis and Wound Management
The extrapolated prevalence was found to be 1,679,353 in Norway and the population esteemed used is double of 104,959,594.
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), supports a broad range of research on pemphigus to better understand what causes various forms of the disease and to develop better treatments.